Our Mission

Truly biomimetic

Utilizing a passionate and talented team, VoxCell is providing an extraordinary line of Truly Biomimetic solutions for the drug development industry and the field of Oncology research,  by creating 3D vascularized cancer tissue models. Our 3D Bioprinter uses a state of the art laser with a process that crosslinks bioink with extreme precision, producing incredible high resolution 3D bioprinted tissues. Combined with our proprietary software, we are able to print tissues with vasculature for more meaningful in vitro testing. This process occurs only at the focal point of the laser (the voxel, hence VoxCell), allowing for printing anywhere in the polymer, including within structures, unlike traditional extrusion based 3D bioprinters.

Our tissue models will increase confidence in new drug candidates, decrease the failure rate (currently more than 95% of drugs in the pipeline fail), and impact the speed for new therapies to get to market. The successful translation between pre-clinical trial data and clinical trial results is less than 8% and we are on a mission to change that.

 

Testing on truly biomimetic tissues will provide better data to identify and eliminate unsuccessful drug candidates sooner, increasing the throughput and reducing the volume and cost of animal and human testing, ultimately getting life saving therapies to market and in the hands of people who need them sooner.

Meet the team

Karol Small.jpg

Dr. Karolina Valente
CEO, CSO

Christine Small.jpg

Christine Whiteside

COO

Andy Small.jpg

Andrew Garland
Director of Engineering Design

FB_IMG_1532370391877_edited.png

Curtis Evans
Director of Program Management

Davy%2520headshot_edited_edited.jpg

Dr. Emma Davy
Director of Bioink R&D

Cam%20Small_edited.jpg

Cameron Polglase
Lead Product Development Scientist

Austyn Small.jpg

Austyn Roelofs

Lead Engineer

Byron_edited.jpg

Byron Kontou

Software Engineer

jj-ying-7JX0-bfiuxQ-unsplash_edited.jpg

advisors and partners

Brolo Small.jpg

Dr. Alexandre Brolo

Partner

unnamed-5_edited.jpg

Dr. Nathan Lindquist
Advisor, Optics

DCLeitch_edited_edited.jpg

Dr. Dave Leitch
Advisor, Pharma

Leah Small.jpg

Dr. Leah Gajecki
Advisor, Chemistry

MGurbin_edited.jpg

Martin Gurbin
Advisor, Business